![About us About us](/sites/default/files/styles/720_tablet_portrait_fallback/public/media_image-file/2023-04/About-us-banner.jpg?itok=gitrbpub)
![Mission-Icon](/sites/default/files/styles/card_style_fallback/public/media_image-file/2023-04/Mission-Icon-new.jpg?h=57024e64&itok=zC8kzzBo)
Our Mission
Advancing Cancer Diagnostics, Improving Lives
![Vision](/sites/default/files/styles/card_style_fallback/public/media_image-file/2023-04/Vision%20Icon.jpg?h=57024e64&itok=qBB0CnpA)
Our Vision
From translational research to patient treatment, we envision a world where comprehensive insights enrich cancer diagnosis and offer reassurance to all patients.
News & Events
Leica Biosystems and Navinci Partner to Accelerate Cancer Research Through First-Ever Fully Automated In Situ Proximity Ligation Assays
Leica Biosystems, a global leader in anatomic pathology, and Navinci, a leader in developing innovative solutions for studying protein interactions, announce a strategic collaboration to drive innovation in cancer patient care.
Leica Biosystems Melbourne Finalist for 2023 Victorian Manufacturing Hall of Fame Award
The company’s latest Advanced Staining Solution, BOND-PRIME, is primarily manufactured in Melbourne, Australia MELBOURNE – Leica Biosystems is pleased to announce that the company is a finalist for the 2023 Victorian Manufacturing Hall of Fame Award for Manufacturer of the Year (Large Business).…
Leica Biosystems Strengthens Portfolio with FDA Clearance of Class II Mismatch Repair (MMR) Panel
The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments.
Leica Biosystems at a Glance
![About US](/sites/default/files/styles/720_tablet_portrait_fallback/public/media_image-file/2023-04/about-us-number.jpg?itok=BXfKVZt9)
150+ Years of Innovation
2012 - Present |
New Era of Science & Technology |
2005 - 2011 |
Global Expansion Accelerates |
1989 - 2004 |
Structuring for Comprehensive Workflow |
1930 - 1988 |
Novel Products Drive Company Growth |
1900 - 1930 |
Microtomy Technology Advances Amidst Wartime Realities |
1872 - 1899 |
The Creation of the Microtome and the Early Years of R. Jung GMBH |
About Danaher
Leica Biosystems is proud to be part of Danaher. Danaher’s science and technology leadership puts Leica Biosystems’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.